Publications
Found 1 results
Filters: Author is M. Karadag [Clear All Filters]
“Lack of association of ACE gene I/D polymorphism with obstructive sleep apnea syndrome in Turkish patients”, vol. 9, pp. 734-738, 2010.
, Agerholm-Larsen B, Nordestgaard BG and Tybjaerg-Hansen A (2000). ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites. Arterioscler. Thromb. Vasc. Biol. 20: 484-492.
http://dx.doi.org/10.1161/01.ATV.20.2.484
PMid:10669647
Ahmadi N, Shapiro GK, Chung SA and Shapiro CM (2009). Clinical diagnosis of sleep apnea based on single night of polysomnography vs. two nights of polysomnography. Sleep Breath. 13: 221-226.
http://dx.doi.org/10.1007/s11325-008-0234-2
PMid:19067010
Barceló A, Elorza MA, Barbé F, Santos C, et al. (2001). Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms. Eur. Respir. J. 17: 728-732.
http://dx.doi.org/10.1183/09031936.01.17407280
PMid:11401071
Bengtsson K, Orho-Melander M, Lindblad U, Melander O, et al. (1999). Polymorphism in the angiotensin converting enzyme but not in the angiotensinogen gene is associated with hypertension and type 2 diabetes: the Skaraborg Hypertension and Diabetes Project. J. Hypertens. 17: 1569-1575.
http://dx.doi.org/10.1097/00004872-199917110-00010
PMid:10608470
Butler R, Morris AD and Struthers AD (1997). Angiotensin-converting enzyme gene polymorphism and cardiovascular disease. Clin. Sci. 93: 391-400.
PMid:9486084
Candy GP, Skudicky D, Mueller UK, Woodiwiss AJ, et al. (1999). Association of left ventricular systolic performance and cavity size with angiotensin-converting enzyme genotype in idiopathic dilated cardiomyopathy. Am. J. Cardiol. 83: 740-744.
http://dx.doi.org/10.1016/S0002-9149(98)00981-3
Lee YJ and Tsai JC (2002). ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 25: 1002-1008.
http://dx.doi.org/10.2337/diacare.25.6.1002
PMid:12032106
Nakai K, Itoh C, Miura Y, Musya T, et al. (1994). Deletion polymorphism of the angiotensin I-converting enzyme gene associates with increased risk for ischemic heart diseases in the Japanese. Rinsho Byori 42: 689-694.
PMid:8065033
O'Donnell CJ, Lindpaintner K, Larson MG, Rao VS, et al. (1998). Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 97: 1766-1772.
http://dx.doi.org/10.1161/01.CIR.97.18.1766
PMid:9603529
Patel SR, Larkin EK, Mignot E, Lin L, et al. (2007). The association of angiotensin converting enzyme (ACE) polymorphisms with sleep apnea and hypertension. Sleep 30: 531-533.
PMid:17520798
Piérola J, Barceló A, de la Pe-a M, Barbé F, et al. (2007). Beta3-adrenergic receptor Trp64Arg polymorphism and increased body mass index in sleep apnoea. Eur. Respir. J. 30: 743-747.
http://dx.doi.org/10.1183/09031936.00152006
PMid:17626108
Raynolds MV, Bristow MR, Bush EW, Abraham WT, et al. (1993). Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 342: 1073-1075.
http://dx.doi.org/10.1016/0140-6736(93)92061-W
Rubinsztajn R, Kumor M, Byskiniewicz K and Chazan R (2004). Angiotensin-converting enzyme gene polymorphism in patients with obstructive sleep apnea. Pol. Arch. Med. Wewn. 112: 817-822.
PMid:15526842
Sakai K, Takada T, Nakayama H, Kubota Y, et al. (2005). Serotonin-2A and 2C receptor gene polymorphisms in Japanese patients with obstructive sleep apnea. Intern. Med. 44: 928-933.
http://dx.doi.org/10.2169/internalmedicine.44.928
PMid:16258205
Schunkert H, Hense HW, Holmer SR, Stender M, et al. (1994). Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N. Engl. J. Med. 330: 1634-1638.
http://dx.doi.org/10.1056/NEJM199406093302302
PMid:8177269
Seckin D, Ilhan N, Ilhan N and Ozbay Y (2006). The relationship between ACE insertion/deletion polymorphism and coronary artery disease with or without myocardial infarction. Clin. Biochem. 39: 50-54.
http://dx.doi.org/10.1016/j.clinbiochem.2005.10.003
PMid:16303122
Ursavaş A and Ege E (2003). Obstructive sleep apnea and cardiovascular diseases. Anadolu. Kardiyol. Derg. 3: 150-155.
PMid:12826511
Xiao Y, Huang X, Qiu C, Zhu X, et al. (1999). Angiotensin I-converting enzyme gene polymorphism in Chinese patients with obstructive sleep apnea syndrome. Chin. Med. J. 112: 701-704.
Yaggi HK, Concato J, Kernan WN, Lichtman JH, et al. (2005). Obstructive sleep apnea as a risk factor for stroke and death. N. Engl. J. Med. 353: 2034-2041.
http://dx.doi.org/10.1056/NEJMoa043104
PMid:16282178
Yavuz Z, Ursavas A, Ege E, Ozarda IY, et al. (2008). Homocysteine levels in patients with obstructive sleep apnea syndrome. Tuberk. Toraks 56: 37-42.
PMid:18330753